MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer
Autor: | Wen Guo Jiang, Xiaofang Xing, Xiaojing Cheng, Hong Du, Meng Xie, Jiafu Ji, Ting Guo, Dafydd Alwyn Dart, Xian-Zi Wen |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Oncology Adult Male Vascular Endothelial Growth Factor A Cancer Research medicine.medical_specialty Angiogenesis Adenocarcinoma law.invention 03 medical and health sciences 0302 clinical medicine Surgical oncology law Stomach Neoplasms Internal medicine microRNA medicine Humans Genes Tumor Suppressor Oncology & Carcinogenesis Aged MicroRNA sequencing Endothelin-1 Neovascularization Pathologic business.industry Gastroenterology General Medicine Middle Aged medicine.disease Endothelin 1 miR-1 Gene Expression Regulation Neoplastic Vascular endothelial growth factor A MicroRNAs 030104 developmental biology 030220 oncology & carcinogenesis Suppressor Female Original Article business Gastric cancer |
Zdroj: | Gastric Cancer |
ISSN: | 1436-3305 1436-3291 |
Popis: | Background We recently reported that miR-1 was one of the most significantly downregulated microRNAs in gastric cancer (GC) patients from The Cancer Genome Atlas microRNA sequencing data. Here we aim to elucidate the role of miR-1 in gastric carcinogenesis. Methods We measured miR-1 expression in human GC cell lines and 90 paired primary GC samples, and analyzed the association of its status with clinicopathological features. The effect of miR-1 on GC cells was evaluated by proliferation and migration assay. To identify the target genes of miR-1, bioinformatic analysis and protein array analysis were performed. Moreover, the regulation mechanism of miR-1 with regard to these predicted targets was investigated by quantitative PCR (qPCR), Western blot, ELISA, and endothelial cell tube formation. The putative binding site of miR-1 on target genes was assessed by a reporter assay. Results Expression of miR-1 was obviously decreased in GC cell lines and primary tissues. Patients with low miR-1 expression had significantly shorter overall survival compared with those with high miR-1 expression (P = 0.0027). Overexpression of miR-1 in GC cells inhibited proliferation, migration, and tube formation of endothelial cells by suppressing expression of vascular endothelial growth factor A (VEGF-A) and endothelin 1 (EDN1). Conversely, inhibition of miR-1 with use of antago-miR-1 caused an increase in expression of VEGF-A and EDN1 in nonmalignant GC cells or low-malignancy GC cells. Conclusions MiR-1 acts as a tumor suppressor by inhibiting angiogenesis-related growth factors in human gastric cancer. Downregulated miR-1 not only promotes cellular proliferation and migration of GC cells, but may activates proangiogenesis signaling and stimulates the proliferation and migration of endothelial cells, indicating the possibility of new strategies for GC therapy. Electronic supplementary material The online version of this article (doi:10.1007/s10120-017-0721-x) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |